Lyme borreliosis is a multisystemic tick-borne spirochetosis, which may result in dermatologic, musculoskeletal, cardiovascular, and neurologic manifestations.
Objective:
Patients with suspected acute Lyme borreliosis infection may be referred for urgent dermatologic review. Canadian dermatologists should be aware of the latest information regarding the diagnosis and management of Lyme borreliosis.
Methods:
This review is based on a PubMed database search combining the word “Lyme” with variations of the word “Canada.” Data sources included articles from the fields of ecology, epidemiology, laboratory diagnostics, and clinical management.
Conclusion:
In this review, the ecological basis of spirochete transmission by tick vectors is described. The latest available Canadian epidemiologic data are summarized. North American clinical manifestations of Lyme borreliosis are contrasted with European presentations. The Canadian Public Health Laboratory Network's diagnostic guidelines are summarized. Finally, treatment recommendations are outlined.
Get full access to this article
View all access options for this article.
References
1.
SteereACMalawistaSESnydmanDR. Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum1977;20:7–17, doi:10.1002/art.1780200102.
KurtenbachKHanincovaKTsaoJI. Fundamental processes in the evolutionary ecology of Lyme borreliosis. Nat Rev Microbiol2006;4:660–9, doi:10.1038/nrmicro1475.
4.
MarquesAR. Lyme disease: An update. Curr Allergy Asthma Rep2001;1:541–9, doi:10.1007/s11882-001-0063-x.
5.
OgdenNHTrudelLArtsobH. Ixodes scapularis ticks collected by passive surveillance in Canada: Analysis of geographic distribution and infection with Lyme borreliosis agent Borrelia burgdorferi. J Med Entomol2006;43:600–9, doi:10.1603/0022-2585(2006)43[600:ISTCBP]2.0.C0;2.
CrippaMRaisOGernL. Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks. Vector Borne Zoonotic Dis2002;2:3–9, doi:10.1089/153036602760260724.
8.
WormserGPDattwylerRJShapiroED. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis2006;43:1089–134, doi:10.1086/508667.
9.
EwingCScorpioANelsonDR. Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis. J Clin Microbiol1994;32:755–8.
10.
KumarMYangXColemanAS. BBA52 facilitates Borrelia burgdorferi transmission from feeding ticks to murine hosts. J Infect Dis2010;201:1084–95, doi:10.1086/651172.
11.
PiesmanJSchneiderBS. Dynamic changes in Lyme disease spirochetes during transmission by nymphal ticks. Exp Appl Acarol2002;28:141–5, doi:10.1023/A:1025351727785.
12.
Centers for Disease Control and Prevention. Lyme disease— United States, 2003–2005. MMWR Morb Mortal Wkly Rep2007; 56:573–6.
13.
VrbovaLMiddletonD. Descriptive epidemiology of Lyme disease in Ontario: 1999–2004. Can Commun Dis Rep2006;32:247–57.
Lyme disease in Canada: Q & A for paediatricians. Can J Infect Dis Med Microbiol2009;20:42–4.
16.
OgdenNHLindsayLRMorshedM. The rising challenge of Lyme borreliosis in Canada. Can Commun Dis Rep2008;34:1–19.
17.
HenryBMorshedM. Lyme disease in British Columbia: Are we really missing an epidemic?Br Columbia Med J2011;53:224–9.
18.
LindsayLRBarkerIKSurgeonerGA. Duration of Borrelia burgdorferi infectivity in white-footed mice for the tick vector Ixodes scapularis under laboratory and field conditions in Ontario. J Wildl Dis1997;33:766–75.
19.
Consensus conference on Lyme disease. CMAJ1991;144:1627–32.
20.
MakSMorshedMHenryB. Ecological niche modeling of Lyme disease in British Columbia, Canada. J Med Entomol2010;47:99–105, doi:10.1603/033.047.0114.
21.
OgdenNHMaaroufABarkerIK. Climate change and the potential for range expansion of the Lyme disease vector Ixodes scapularis in Canada. Int J Parasitol2006;36:63–70, doi:10.1016/j.ijpara.2005.08.016.
22.
OgdenNHBouchardCKurtenbachK. Active and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in Canada. Environ Health Perspect2010;118:909–14, doi:10.1289/ehp.0901766.
23.
DandachePNadelmanRB. Erythema migrans. Infect Dis Clin North Am2008;22:235–60, vi, doi:10.1016/j.idc.2007.12.012.
24.
MulleggerRRGlatzM. Skin manifestations of Lyme borreliosis: Diagnosis and management. Am J Clin Dermatol2008;9:355–68, doi:10.2165/0128071-200809060-00002.
NadelmanRBNowakowskiJForseterG. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med1996;100:502–8, doi:10.1016/S0002-9343(95)99915-9.
27.
SmithRPSchoenRTRahnDW. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med2002;136:421–8.
28.
SteereACBartenhagenNHCraftJE. The early clinical manifestations of Lyme disease. Ann Intern Med1983;99:76–82.
29.
OgdenNHArtsobHLindsayLR. Lyme disease: A zoonotic disease of increasing importance to Canadians. Can Fam Physician2008;54:1381–4.
30.
NagiKSJoshiRThakurRK. Cardiac manifestations of Lyme disease: A review. Can J Cardiol1996;12:503–6.
31.
PuiusYAKalishRA. Lyme arthritis: Pathogenesis, clinical presentation, and management. Infect Dis Clin North Am2008; 22:289–300, vi–vii, doi:10.1016/j.idc.2007.12.014.
KrafchikB. Lyme disease. Int J Dermatol1989;28:71–4, doi:10.1111/j.1365-4362.1989.tb01321.x.
34.
Canadian Public Health Laboratory Network. The laboratory diagnosis of Lyme borreliosis: Guidelines from the Canadian Public Health Laboratory Network. Can J Infect Dis Med Microbiol2007; 18:145–8.
35.
Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep1995;44:590–1.
36.
BrattonRLWhitesideJWHovanMJ. Diagnosis and treatment of Lyme disease. Mayo Clin Proc2008;83:566–71.
37.
LipskerDLieber-MbomeyoAHedelinG. How accurate is a clinical diagnosis of erythema chronicum migrans? Prospective study comparing the diagnostic accuracy of general practitioners and dermatologists in an area where Lyme borreliosis is endemic. Arch Dermatol2004;140:620–1, doi:10.1001/archderm.140.5.620.
38.
LedueTBCollinsMFCraigWY. New laboratory guidelines for serologic diagnosis of Lyme disease: Evaluation of the two-test protocol. J Clin Microbiol1996;34:2343–50.
39.
WeissNLSadockVASigalLH. False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: The value of immunoblot analysis. Lupus1995;4:131–7, doi:10.1177/096120339500400209.
40.
BergerBW. Erythema chronicum migrans of Lyme disease. Arch Dermatol1984;120:1017–21, doi:10.1001/archderm.1984.01650440047017.
